stockrowDBV Technologies S.A. (DBVT) vs Zevra Therapeutics, Inc. (ZVRA)
- DBV Technologies S.A. DBVT 10.57 +7.86%
- Zevra Therapeutics, Inc. ZVRA 11.55 +9.69%
DBV Technologies S.A. and Zevra Therapeutics, Inc. are both Biotechnology companies. DBV Technologies S.A. and Zevra Therapeutics, Inc. are of similar size ($626.6M and $615.8M). DBV Technologies S.A. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 9.0×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 75.1% against −33.4%. Zevra Therapeutics, Inc. has the higher net margin (50.7% vs −5,547.3%) and the higher return on invested capital (129.5% vs 0.00%). Across the 18 metrics below, Zevra Therapeutics, Inc. leads on 16 and DBV Technologies S.A. on 2.
Valuation
Profitability
| Metric | DBVT | ZVRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 95.44% | 68.51% |
| Operating margin | (5,571.63%) | 60.78% | 0.00% |
| Net margin | (5,547.30%) | 50.73% | 0.00% |
| Free cash flow margin | (5,131.50%) | 58.93% | 0.00% |
| Return on equity | (205.75%) | 40.29% | (51.96%) |
| Return on assets | (127.19%) | 25.69% | (46.06%) |
| Return on invested capital | 0.00% | 129.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack